Cargando…

Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

The present review details a chronological description of the events that took place during the development of mesoporous materials, their different synthetic routes and their use as drug delivery systems. The outstanding textural properties of these materials quickly inspired their translation to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallet-Regí, María, Schüth, Ferdi, Lozano, Daniel, Colilla, Montserrat, Manzano, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252171/
https://www.ncbi.nlm.nih.gov/pubmed/35642539
http://dx.doi.org/10.1039/d1cs00659b
_version_ 1784740205414055936
author Vallet-Regí, María
Schüth, Ferdi
Lozano, Daniel
Colilla, Montserrat
Manzano, Miguel
author_facet Vallet-Regí, María
Schüth, Ferdi
Lozano, Daniel
Colilla, Montserrat
Manzano, Miguel
author_sort Vallet-Regí, María
collection PubMed
description The present review details a chronological description of the events that took place during the development of mesoporous materials, their different synthetic routes and their use as drug delivery systems. The outstanding textural properties of these materials quickly inspired their translation to the nanoscale dimension leading to mesoporous silica nanoparticles (MSNs). The different aspects of introducing pharmaceutical agents into the pores of these nanocarriers, together with their possible biodistribution and clearance routes, would be described here. The development of smart nanocarriers that are able to release a high local concentration of the therapeutic cargo on-demand after the application of certain stimuli would be reviewed here, together with their ability to deliver the therapeutic cargo to precise locations in the body. The huge progress in the design and development of MSNs for biomedical applications, including the potential treatment of different diseases, during the last 20 years will be collated here, together with the required work that still needs to be done to achieve the clinical translation of these materials. This review was conceived to stand out from past reports since it aims to tell the story of the development of mesoporous materials and their use as drug delivery systems by some of the story makers, who could be considered to be among the pioneers in this area.
format Online
Article
Text
id pubmed-9252171
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-92521712022-07-20 Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? Vallet-Regí, María Schüth, Ferdi Lozano, Daniel Colilla, Montserrat Manzano, Miguel Chem Soc Rev Chemistry The present review details a chronological description of the events that took place during the development of mesoporous materials, their different synthetic routes and their use as drug delivery systems. The outstanding textural properties of these materials quickly inspired their translation to the nanoscale dimension leading to mesoporous silica nanoparticles (MSNs). The different aspects of introducing pharmaceutical agents into the pores of these nanocarriers, together with their possible biodistribution and clearance routes, would be described here. The development of smart nanocarriers that are able to release a high local concentration of the therapeutic cargo on-demand after the application of certain stimuli would be reviewed here, together with their ability to deliver the therapeutic cargo to precise locations in the body. The huge progress in the design and development of MSNs for biomedical applications, including the potential treatment of different diseases, during the last 20 years will be collated here, together with the required work that still needs to be done to achieve the clinical translation of these materials. This review was conceived to stand out from past reports since it aims to tell the story of the development of mesoporous materials and their use as drug delivery systems by some of the story makers, who could be considered to be among the pioneers in this area. The Royal Society of Chemistry 2022-06-01 /pmc/articles/PMC9252171/ /pubmed/35642539 http://dx.doi.org/10.1039/d1cs00659b Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Vallet-Regí, María
Schüth, Ferdi
Lozano, Daniel
Colilla, Montserrat
Manzano, Miguel
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
title Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
title_full Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
title_fullStr Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
title_full_unstemmed Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
title_short Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
title_sort engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252171/
https://www.ncbi.nlm.nih.gov/pubmed/35642539
http://dx.doi.org/10.1039/d1cs00659b
work_keys_str_mv AT valletregimaria engineeringmesoporoussilicananoparticlesfordrugdeliverywhereareweaftertwodecades
AT schuthferdi engineeringmesoporoussilicananoparticlesfordrugdeliverywhereareweaftertwodecades
AT lozanodaniel engineeringmesoporoussilicananoparticlesfordrugdeliverywhereareweaftertwodecades
AT colillamontserrat engineeringmesoporoussilicananoparticlesfordrugdeliverywhereareweaftertwodecades
AT manzanomiguel engineeringmesoporoussilicananoparticlesfordrugdeliverywhereareweaftertwodecades